Quillaja brasiliensis saponin-based iscom matrix
Quillaja brasiliensis saponin-based iscom matrix has been studied in 1 paper since 2024: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Aug 9, 2024: “Intranasal Delivery of Quillaja brasiliensis Saponin-Based Nanoadjuvants Improve Humoral Immune Response of Influenza Vaccine in Aged Mice”.
1 paper studies itUpdated
See all 1 papers on quillaja brasiliensis saponin-based iscom matrix
- Animals1